Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases

被引：0
作者：
Wasan, Harpreet S. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Canc Med, London, England
来源：
FUTURE ONCOLOGY | 2014年 / 10卷 / 15期
关键词：
colorectal cancer; liver metastases; selective internal radiation therapy; PHASE-3; TRIAL; CANCER; CHEMOTHERAPY; CETUXIMAB; FLUOROURACIL; SURGERY; FOLFOX4;
D O I：
10.2217/fon.14.220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 36
页数：4
相关论文
共 14 条
  • [1] Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
    Bokemeyer, C.
    Bondarenko, I.
    Hartmann, J. T.
    de Braud, F.
    Schuch, G.
    Zubel, A.
    Celik, I.
    Schlichting, M.
    Koralewski, P.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (07) : 1535 - 1546
  • [2] Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
    Folprecht, G.
    Gruenberger, T.
    Bechstein, W.
    Raab, H. -R.
    Weitz, J.
    Lordick, F.
    Hartmann, J. T.
    Stoehlmacher-Williams, J.
    Lang, H.
    Trarbach, T.
    Liersch, T.
    Ockert, D.
    Jaeger, D.
    Steger, U.
    Suedhoff, T.
    Rentsch, A.
    Koehne, C. -H.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (05) : 1018 - 1025
  • [3] Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel
    Van Cutsem, Eric
    Sobrero, Alberto
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Cupit, Lisa
    Wagner, Andrea
    Laurent, Dirk
    [J]. LANCET, 2013, 381 (9863) : 303 - 312
  • [4] Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
    Hendlisz, Alain
    Van den Eynde, Marc
    Peeters, Marc
    Maleux, Geert
    Lambert, Bieke
    Vannoote, Jaarke
    De Keukeleire, Katrien
    Verslype, Chris
    Defreyne, Luc
    Van Cutsem, Eric
    Delatte, Philippe
    Delaunoit, Thierry
    Personeni, Nicola
    Paesmans, Marianne
    Van Laethem, Jean-Luc
    Flamen, Patrick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3687 - 3694
  • [5] K-ras mutations and benefit from cetuximab in advanced colorectal cancer
    Karapetis, Christos S.
    Khambata-Ford, Shirin
    Jonker, Derek J.
    O'Callaghan, Chris J.
    Tu, Dongsheng
    Tebbutt, Niall C.
    Simes, R. John
    Chalchal, Haji
    Shapiro, Jeremy D.
    Robitaille, Sonia
    Price, Timothy J.
    Shepherd, Lois
    Au, Heather-Jane
    Langer, Christiane
    Moore, Malcolm J.
    Zalcberg, John R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) : 1757 - 1765
  • [6] Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
    Maughan, Timothy S.
    Adams, Richard A.
    Smith, Christopher G.
    Meade, Angela M.
    Seymour, Matthew T.
    Wilson, Richard H.
    Idziaszczyk, Shelley
    Harris, Rebecca
    Fisher, David
    Kenny, Sarah L.
    Kay, Edward
    Mitchell, Jenna K.
    Madi, Ayman
    Jasani, Bharat
    James, Michelle D.
    Bridgewater, John
    Kennedy, M. John
    Claes, Bart
    Lambrechts, Diether
    Kaplan, Richard
    Cheadle, Jeremy P.
    [J]. LANCET, 2011, 377 (9783) : 2103 - 2114
  • [7] Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
    Nordlinger, Bernard
    Sorbye, Halfdan
    Glimelius, Bengt
    Poston, Graeme J.
    Schlag, Peter M.
    Rougier, Philippe
    Bechstein, Wolf O.
    Primrose, John N.
    Euan, T. Walpole
    Finch-Jones, Meg
    Jaeck, Daniel
    Mirza, Darius
    Parks, Rowan W.
    Collette, Laurence
    Praet, Michel
    Bethe, Ullrich
    Van Cutsem, Eric
    Scheithauer, Werner
    Gruenberger, Thomas
    [J]. LANCET, 2008, 371 (9617) : 1007 - 1016
  • [8] Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
    Nordlinger, Bernard
    Sorbye, Halfdan
    Glimelius, Bengt
    Poston, Graeme J.
    Schlag, Peter M.
    Rougier, Philippe
    Bechstein, Wolf O.
    Primrose, John N.
    Walpole, Euan T.
    Finch-Jones, Meg
    Jaeck, Daniel
    Mirza, Darius
    Parks, Rowan W.
    Mauer, Murielle
    Tanis, Erik
    Van Cutsem, Eric
    Scheithauer, Werner
    Gruenberger, Thomas
    [J]. LANCET ONCOLOGY, 2013, 14 (12) : 1208 - 1215
  • [9] Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
    Peeters, Marc
    Price, Timothy Jay
    Cervantes, Andres
    Sobrero, Alberto F.
    Ducreux, Michel
    Hotko, Yevhen
    Andre, Thierry
    Chan, Emily
    Lordick, Florian
    Punt, Cornelis J. A.
    Strickland, Andrew H.
    Wilson, Gregory
    Ciuleanu, Tudor-Eliade
    Roman, Laslo
    Van Cutsem, Eric
    Tzekova, Valentina
    Collins, Simon
    Oliner, Kelly S.
    Rong, Alan
    Gansert, Jennifer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) : 4706 - 4713
  • [10] Primrose JN, 2013, J CLIN ONCOL SUPPL, V31
12